Drug Manufacturers

Transforming Glycosciences in the US

By glyXera

In response to a request from the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the US Department of Energy (DoE), and the National Science Foundation (NSF), the National Research Council convened a committee to assess the importance and impact of glycoscience, explore the landscape of current research, and identify the challenges that will need to be addressed to enable the field to move forward.

The committee was charged to 'articulate a unified vision for the field on glycoscience and glycomics' and to 'develop a roadmap with concrete research goals to significantly advance [the field]'.

The committee's consensus findings, conclusions, and recommendations in addressing this charge are summarised in this document.

Download to find out more.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.